Caris Life Sciences, Inc.

1. 01

   Behind SPY and its sector fund XLV over 1 year

   1 month: +21.0% (SPY −1.6%, XLV +13.5%). 3 months: +101.9% (SPY −0.4%, XLV +15.5%). 1 year: +6.5% (SPY +13.6%, XLV +30.7%). Price change to the 4 Nov 2026 close; dividends excluded.

   Daily closes, split-adjusted: CAI, SPY and XLV · as of 4 Nov 2026

2. 02

   9.0% below its 52-week high

   Closed at $33.22 on 4 Nov 2026: 9.0% below the 52-week high of $36.50 (28 Oct 2026) and 134.1% above the low of $14.19 (13 May 2026).

   Daily price bars, split-adjusted · as of 4 Nov 2026

3. 03

   Above its 50- and 200-day averages

   The 4 Nov 2026 close of $33.22 was 12.5% above its 50-day average ($29.52) and 53.3% above its 200-day average ($21.67). It has closed above the 200-day for 55 sessions, since 19 Aug 2026. The 50-day average crossed above the 200-day on 16 Sep 2026, 35 sessions ago.

   Daily closes, split-adjusted; 50- and 200-session simple averages · as of 4 Nov 2026

4. 04

   13.6M shares sold short

   13.6M shares were sold short at the 15 Oct 2026 settlement; covering them would take 3.2 days of average volume. Short interest is reported twice a month, on a lag.

   Exchange short-interest filing · as of 15 Oct 2026

At the 4 Nov 2026 close